Quest Diagnostics Inc. Stock
Price
Target price
€162.40
€162.40
-1.310%
-2.1
-1.310%
€172.34
17.10.25 / Tradegate
WKN: 904533 / Symbol: DGX / Name: Quest Diagnostcs / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Quest Diagnostics Inc. Stock
A loss of -1.310% shows a downward development for Quest Diagnostics Inc..
Quest Diagnostics Inc. is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
As a result the target price of 172 € shows a slightly positive potential of 5.91% compared to the current price of 162.4 € for Quest Diagnostics Inc..
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | -1.310% | 2.428% | 5.352% | 18.023% | 12.077% | 24.827% | 57.670% |
| Anthem Inc. | 0.270% | -1.807% | 14.571% | -27.299% | -15.162% | -38.430% | 17.916% |
| HCA Holdings Inc. | 0.700% | 2.098% | 8.052% | -2.770% | 27.089% | 77.875% | 216.565% |
| Universal Health Services B | -0.570% | 4.142% | 8.642% | -19.266% | 2.924% | 85.732% | 82.383% |
Comments
Quest Diagnostics Incorporated (NYSE: DGX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics Incorporated (NYSE: DGX) had its price target raised by analysts at Robert W. Baird from $191.00 to $194.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics Incorporated (NYSE: DGX) had its price target raised by analysts at Mizuho from $178.00 to $189.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for DGX provided by MarketBeat
